Acublate Overview

  • Founded
  • 2010
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Acublate General Information

Description

Provider of therapeutic services designed to offer novel ultrasound device for the treatment of cancer. The company's therapeutic services include development of devices that use phased array technology consisting of transducers, resulting in focused beams that can be steered in three-dimensional imaging, providing consumers with ultrasound surgery devices to treat and melt cancer tumors.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Primary Office
  • Angel Building
  • 407 Saint John Street
  • London EC1V 4AD
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Acublate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 05-Feb-2019 00000 Completed Out of Business
1. Early Stage VC 27-Jan-2012 00000 00000 00.000 Completed Startup
To view Acublate’s complete valuation and funding history, request access »

Acublate Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000 0000 0000 00 0000 00.000
To view Acublate’s complete cap table history, request access »